Navigation Links
FDA, States Weigh Pharmacy Regulation in Wake of Meningitis Outbreak
Date:12/20/2012

THURSDAY, Dec. 20 (HealthDay News) -- State public health officials want the U.S. Food and Drug Administration to play a stronger role in regulating large-scale compounding pharmacies to prevent tragedies like the recent nationwide meningitis outbreak, officials said at a meeting in Washington, D.C., on Wednesday.

Health officials from 50 states and FDA representatives met to discuss regulatory concerns after contaminated vials of a steroid medication for back and joint pain sickened 620 people with meningitis in 19 states. Thirty-nine have died. All received injections for back pain made by a Massachusetts-based specialty drug firm called the New England Compounding Center.

Typically, states -- not the FDA -- govern pharmacies, but many states lack the resources to oversee large-scale operations such as the New England Compounding Center (NECC), the state officials said, according to The New York Times.

"The consensus in our group was that there is a role for the FDA to be involved in facilities like NECC," Cody Wiberg, executive director of the Minnesota Board of Pharmacy, told the Times. "If you're talking about compounding, most states have the authority and resources to handle that," he said. Not as many states can effectively oversee manufacturing enterprises such as the New England Compounding Center, he added.

Compounding pharmacies mix or alter ingredients to create drugs to meet specific needs of individual patients, but the business has mushroomed since the 1990s. And FDA Commissioner Dr. Margaret Hamburg told the newspaper that the laws have not kept pace with changes in the industry.

"It is very clear that the health care system has evolved and the role of the compounding pharmacies has really shifted," said Hamburg, who called for greater oversight by the FDA in testimony before Congress last month.

But she and others expressed concern that heavy-handed measures might harm the health care system. The ability to tailor medications to individual patients is important, experts noted.

Some critics have said the FDA has shirked its responsibilities. "There should be one uniform federal standard that is enforced by one agency -- the FDA," Michael Carome, deputy director of the consumer advocacy organization Public Citizen's Health Research Group, told the Times. "They have been lax in enforcing that standard."

The New England Compounding Center ceased operations after the start of the meningitis outbreak early in October.

Compounding pharmacies aren't subject to the same FDA oversight as regular drug manufacturers. Some members of Congress have called for greater FDA regulation of these businesses.

The owner of the New England Compounding Center refused last month to testify before a House of Representatives committee investigating the steroid/meningitis outbreak.

Meningitis is inflammation of the membranes that surround the brain and spinal cord. The steroid injections were used on patients complaining of back or joint pain.

FDA investigators who toured the New England Compounding Center's Framingham plant found foreign, "greenish-black" material in some vials of the injectable steroid suspected as the cause of the illnesses, federal health officials said. The contaminated product was one of a host of potential violations discovered during the recent inspection, the officials said.

The CDC and state health departments estimate that roughly 14,000 patients may have gotten steroid injections from the New England Compounding Center.

More information

The U.S. National Library of Medicine has more about injections for back pain.

-- HealthDay staff

SOURCE: The New York Times; U.S. Food and Drug Administration


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Majority of states fail to address youth exposure to alcohol marketing
2. Injury-Linked Deaths Vary Widely Among States
3. Strokes More Common in Southern States: CDC
4. States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds
5. Ohio Mail-Order Hatchery Now Linked to Salmonella in 23 States
6. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
7. States' Next Steps on Health Reform - Will They Launch Exchanges?
8. Lung cancer death rates among young and middle-aged white women climb in some states
9. New study finds increase in track-related injuries among youth in the United States
10. Reducing Ozone Limits Would Save Lives, Report States
11. New FDA program adds to tools to curb opiod abuse in United States
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA, States Weigh Pharmacy Regulation in Wake of Meningitis Outbreak
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Ellevate Network, ... in business to advocate for action towards gender equality at their inaugural Summit in ... around the globe, and reached a social audience of over 3 million. To watch ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an ... Puerto Rico , where the company ... Following a comprehensive onsite assessment, ... damage, temporary loss of power and minimal water damage ... operations have resumed, and the company expects to return ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
Breaking Medicine Technology: